Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pacilio

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Endocrinology|August 15, 2000
The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completionL Cicatiello, R Addeo, L Altucci, et al.
Anticancer Research|August 15, 1998
RB growth control evasion in lung cancerM Caputi, V Esposito, A M Groger, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1999
Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigenM Caputi, A M Groeger, V Esposito, et al.
Breast Cancer Research and Treatment|August 24, 2001
Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1D Germano, C Pacilio, M Cancemi, et al.
Cancer Research|March 21, 1998
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogensC Pacilio, D Germano, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 2, 1999
Independent prognostic role of p16 expression in lung cancerA M Groeger, M Caputi, V Esposito, et al.
Circulation Research|November 26, 1999
Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplastyP P Claudio, L Fratta, F Farina, et al.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
Cancer Research|February 10, 2000
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transferP P Claudio, C M Howard, C Pacilio, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Endocrinology|August 15, 2000
The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completionL Cicatiello, R Addeo, L Altucci, et al.
Anticancer Research|August 15, 1998
RB growth control evasion in lung cancerM Caputi, V Esposito, A M Groger, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1999
Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigenM Caputi, A M Groeger, V Esposito, et al.
Breast Cancer Research and Treatment|August 24, 2001
Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1D Germano, C Pacilio, M Cancemi, et al.
Cancer Research|March 21, 1998
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogensC Pacilio, D Germano, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 2, 1999
Independent prognostic role of p16 expression in lung cancerA M Groeger, M Caputi, V Esposito, et al.
Circulation Research|November 26, 1999
Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplastyP P Claudio, L Fratta, F Farina, et al.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
Cancer Research|February 10, 2000
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transferP P Claudio, C M Howard, C Pacilio, et al.
Pageof 3